Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review
DOI:
https://doi.org/10.33448/rsd-v10i14.22188Keywords:
Covid19 ; Vitamin D; Suplementação.Abstract
The objective of this review was to assess the effects of vitamin D supplementation in patients affected by COVID-19. In the methodology, a survey was carried out by means of an electronic search in data banks LILACS, PubMed and Cochrane, by articles published in 2020 and 2021. In the initial electronic search, 241 articles were identified in the PubMed base, 68 articles in Cochrane and 3 articles in LILACS on the subject. In the first screening, 187 studies were selected and 125 were excluded by not presenting the words “covid” and “vitamin D”, not title and / or summary. In the second screening, 177 articles were excluded and 10 studies were selected for inclusion in the review. As a result, 4 two 10 included patients with mild COVID-19, while 2 involved patients in serious condition. In relation to life, a majority of two studies involve patients with advanced eating and comorbidities, such as diabetes and hypertension. As a conclusion, vitamin D supplementation is most effective in mild to moderate COVID-19 patients, mainly in patients who had vitamin supplementation before being treated for the disease. Regarding patients with severe COVID-19, the events will show that high doses can generate rapid and satisfactory effects, without time of hospitalization, therefore, or late start of supplementation can be a limiting factor.
References
Albuquerque, A. B. B. (2021). Vitamina D em pacientes com COVID-19: atuais perspectivas. 2021. 34f. Trabalho de Conclusão de Curso, Departamento de Nutrição, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brasil.
Annweiler, G., Corvaisier, M., Gautier, J., Dubée, V., Legrand, E., Sacco, G., & Annweiler, C. (2020). Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study. Nutrients, 12(11), 3377. https://doi.org/10.3390/nu12113377
Annweiler, C., Beaudenon, M., Simon, R., Guenet, M., Otekpo, M., Célarier, T., & Gautier, J. (2021). Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study. The Journal of Steroid Biochemistry and Molecular Biology, 213, 105958. https://doi.org/10.1016/j.jsbmb.2021.105958
Annweiler, C., Hanotte, B., Grandin de l’Eprevier, C., Sabatier, J.-M., Lafaie, L., & Célarier, T. (2020). Vitamin D and survival in COVID-19 patients: A quasi-experimental study. The Journal of Steroid Biochemistry and Molecular Biology, 204, 105771. https://doi.org/10.1016/j.jsbmb.2020.105771
Bleizgys, A. (2020). Vitamin D and COVID‐19: It is time to act. International Journal of Clinical Practice, 75(3). https://doi.org/10.1111/ijcp.13748
Bruyère, O., Deroisy, R., Dardenne, N., Cavalier, E., Coffiner, M., Da Silva, S., De Niet, S., & Reginster, J.-Y. (2015). A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods. Osteoporosis International, 26(12), 2863–2868. https://doi.org/10.1007/s00198-015-3205-z
Cereda, E., Bogliolo, L., de Stefano, L., & Caccialanza, R. (2020). A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019. Current Opinion in Clinical Nutrition & Metabolic Care, 24(1), 102–107. https://doi.org/10.1097/mco.0000000000000701
Carpagnano, G. E., Di Lecce, V., Quaranta, V. N., Zito, A., Buonamico, E., Capozza, E., Palumbo, A., Di Gioia, G., Valerio, V. N., & Resta, O. (2020). Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. Journal of Endocrinological Investigation, 44(4), 765–771. https://doi.org/10.1007/s40618-020-01370-x
Dutra, A. de F. de F. de O., Dias, A. D. C., Araújo, D. G. de S., Silva, E. M. da, Silva, I. M. F. e, & Gomes, L. M. de F. (2020). A importância da alimentação saudável e estado nutricional adequado frente a pandemia de Covid-19. Brazilian Journal of Development, 6(9), 66464–66473. https://doi.org/10.34117/bjdv6n9-181
Fitch, N., Becker, A. B., & HayGlass, K. T. (2016). Vitamin D [1,25(OH)2D3] Differentially Regulates Human Innate Cytokine Responses to Bacterial versus Viral Pattern Recognition Receptor Stimuli. The Journal of Immunology, 196(7), 2965–2972. https://doi.org/10.4049/jimmunol.1500460
Lakkireddy, M., Gadiga, S. G., Malathi, R. D., Karra, M. L., Raju, I. S. S. V. P. M., Ragini, … Kandakatla, M. (2021). Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-90189-4
Manson, J. E., & Bassuk, S. S. (2020). Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action. Metabolism, 112, 154322. https://doi.org/10.1016/j.metabol.2020.154322
Moreira, V. (2018). Vitamina D, a nova arma contra as infeções respiratórias agudas. Revista Portuguesa de Medicina Geral E Familiar, 34(1), 48–50. https://doi.org/10.32385/rpmgf.v34i1.12364
Moreira, T. P., Costa, V. de S., Ferreto, L. E. D., & Wendt, G. W. (2020). Efeitos da vitamina D na prevenção e tratamento da COVID 19: uma revisão sistemática. Research, Society and Development, 9(12), e32191211174. https://doi.org/10.33448/rsd-v9i12.11174
Murai, I. H., Fernandes, A. L., Sales, L. P., Pinto, A. J., Goessler, K. F., Duran, C. S. C., Pereira, R. M. R. (2021). Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19. JAMA, 325(11), 1053. https://doi.org/10.1001/jama.2020.26848.
Notz, Q., Herrmann, J., Schlesinger, T., Kranke, P., Sitter, M., Helmer, P., Stumpner, J., Roeder, D., Amrein, K., Stoppe, C., Lotz, C., & Meybohm, P. (2021). Vitamin D deficiency in critically ill COVID-19 ARDS patients. Clinical Nutrition, 21. https://doi.org/10.1016/j.clnu.2021.03.001
Ohaegbulam, K. C., Swalih, M., Patel, P., Smith, M. A., & Perrin, R. (2020). Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series. American Journal of Therapeutics, 27(5), e485–e490. https://doi.org/10.1097/mjt.0000000000001222
Oliveira, E. de S., Matos, M. F., Cavalcante, O. S. S., Silvestre, J. V. C., Souza, D. E. M. de, & Morais, A. C. L. N. de. (2020). As duas faces da vitamina D como terapia adjuvante na covid-19. InterAmerican Journal of Medicine and Health, 3. https://doi.org/10.31005/iajmh.v3i0.95
Rastogi, A., Bhansali, A., Khare, N., Suri, V., Yaddanapudi, N., Sachdeva, N., Malhotra, P. (2020). Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgraduate Medical Journal, postgradmedj-2020-139065. https://doi.org/10.1136/postgradmedj-2020-139065
Rizzoli, R. (2020). Vitamin D supplementation: upper limit for safety revisited? Aging Clinical and Experimental Research, 33(1), 19–24. https://doi.org/10.1007/s40520-020-01678-x
Sabico, S., Enani, M. A., Sheshah, E., Aljohani, N. J., Aldisi, D. A., Alotaibi, N. H., Al-Daghri, N. M. (2021). Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients, 13(7), 2170. https://doi.org/10.3390/nu13072170
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Isaac Hidekishimada da Silva Rocha; Liejy Agnes dos Santos Raposo Landim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
